New Zealand's PHARMAC says it has initiated a consultation process on a 'provisional bundle' deal with Takeda under which it will fund two medicines that have been reimbursed through the PBS for more than five years.
PHARMAC launches consultation process on 'provisional bundle' deal
September 23, 2022 Latest NewsBioPharma
Latest Video
New Stories
-
Ombudsman's 'State of the Health Funds Report' confirms a decline in complaints
March 20, 2023 - - Other Health -
Aurora Healthcare and Medibank partner to boost access to mental health care
March 20, 2023 - - Other Health -
Bupa puts First Nations Health at the centre of Reconciliation Action Plan
March 20, 2023 - - Latest News -
Monash University in new partnership with leading Israeli research hospital
March 20, 2023 - - Australian Biotech -
Australian company Clinuvel initiates second trial of new anti-stroke candidate
March 20, 2023 - - Australian Biotech -
Organon partners with foundation to relaunch 'No Limits 4 Girls' program
March 20, 2023 - - Latest News -
Moderna officially launches Australian mRNA fellowship program
March 20, 2023 - - Latest News